For FAQs shake
1.   PELVIC INFLAMMATORY DISEASE
2.   VAGINATIS
3.   PROTECTIVE ANTIBIOTICS IN GYNECOLOGICAL INTERVENTIONS
4.   EMERGENCY CONTRACEPTION
5.   URINARY TRACT INFECTIONS
6.   MEDICAL TREATMENT OF PAIN RELATED TO ENDOMETRIOSIS
7.   PREMATURE RUPTURE OF MEMBRANE
8.   ENDOMETRIC DEATH ‘THE BIRTH OF A STILLBORN EMBRYO’
9.   HEMOSTATIC AGENTS IN OBSTETRICS AND GYNECOLOGY
10.   USE OF ANTISYMPHYTIC AGENTS IN OBSTETRICS AND GYNECOLOGY
11.   BLOOD BLEEDING AFTER CUTTING
12.   PROGRAMMED HOME TREATMENT
13.   NON-INVASIVE PRENATAL TESTING WITH FREE DNA (cfDNA)
14.   THE 1ST TRIMESTER ULTRASOUND
15.   PREVENTION AND TREATMENT OF CYTOMEGLOVITIS INFECTION IN PREGNANT WOMEN AND THE NEONATE (CMV)
16.   OBSTETRIC INJURIES OF THE PERINEUM
17.   IMMUNIZATION DURING PREGNANCY
18.   THROMBOPROTECTION IN PREGNANCY AND PUBLICATION
19.   SUPPLEMENTARY GUIDELINES FOR THROMBOPROTECTION
20.   UNEXPLAINED INFERTILITY
21.   THE CONTROL OF THE INFERIENT COUPLE
22.   DIABETES MELLITUS AND PREGNANCY: PRE-EXISTING TYPE 1 AND 2 DIABETES MELLITUS
23.   DIABETES MELLITUS AND PREGNANCY: GESTATIONAL DIABETES MELLITUS
24.   SHOULDER DYSTOCY
25.   VAGINA CANCER
26.   CERVICAL CANCER
27.   OVARIAN CANCER
28.   ENDOMETRIC CANCER
29.   TERMINATION OF PREGNANCY
30.   OBSTETRICAL CARE RECOMMENDATIONS DURING THE COVID-19 PANDEMIC
31.   VAGINAL TOKETOS AFTER A CAESAREAN SECTION
32.   INDUCTION OF OVULSION IN WOMEN WITH HYPOGONADOTROPHIC HYPOGONADISM AND IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS)
33.   HPV VACCINE
34.   SECONDARY PREVENTION OF CERVICAL CANCER - PAP SAMPLING AND MOLECULAR METHODS
35.   TREATMENT OF CERVICAL INTEPTHIELIAL NEOPLASIA
36.   DIAGNOSIS AND MONITORING OF THE PREGNANT AND HER NEWBORN WHEN THE WOMAN SUFFERS FROM HUMAN MAMMO VIRUS INFECTION
37.   VAGINAL INTEPTHIELIAL NEOPLASIA – DIAGNOSIS AND TREATMENT
38.   VULGATE INTEPTHIELIAL NEOPLASIA – VIN
39.   PRENATAL ADMINISTRATION OF CORTICOSTEROIDS TO REDUCE NEONATAL MORRISONTILITY & MORTALITY
40.   EARLY BREAKING NEWS
41.   TOQUETO CHALLENGE
42.   INDUCTION OF LABOR FROM 39+0 WEEKS IN UNCOMPLICATED PREGNANCY
43.   CAESAREAN SECTION
44.   OVARIAN HYPERSTIMULATION SYNDROME
45.   IMMUNIZATION AGAINST SARS-COV-2 DURING PREGNANCY
46.   THIRD (BOOST) DOSE OF COVID-19 VACCINE
47.   SUPPLEMENTARY INSTRUCTION: BOOST DOSE OF VACCINE AGAINST SARS-COV-2
48.   MONITORING OF THE FETAL HEART RATE (FHR) DURING LABOR
49.   HEART DISEASE AND PREGNANCY
50.   PRENATAL CHECK-UP: MONITORING A SMOOTHLY PROGRESSING, UNCOMPLICATED PREGNANCY
51.   MENOPAUSE – OSTEOPOROSIS
52.   BREAST CANCER
53.   MANAGEMENT OF NAUSEA AND VOMITING OF PREGNANCY
54.   MONITORING TWINS DURING PREGNANCY
55.   STILLBORN EMBRYO
56.   THROMBOPROTECTION IN PREGNANCY AND PUBLICATION
57.   SUPPLEMENTARY GUIDELINE: GOOD PRACTICE FOR THE INVESTIGATION OF THROMBOPHILIA IN OBSTETRICS-GYNAECOLOGY